ADepT Therapy for Depression

This study is looking at a therapy called Augmented Depression Therapy (ADepT) for people experiencing a major depressive episode. ADepT is a type of behavioral therapy that combines different techniques to help manage depression symptoms and improve well-being. Researchers want to understand what patients think about ADepT and how effective it is. You might be able to join if you are 18-65 years old, have been diagnosed with a major depressive episode, and score above 10 on a depression questionnaire (PHQ-9). The study will measure how acceptable the therapy is, how many people complete it, and any side effects over 82 weeks.

Study design
This is an interventional study planning to enroll 40 participants. It is a case series, meaning it will observe the effects of ADepT on a group of individuals.
What's involved
You would attend 15 therapy sessions, typically weekly and lasting about 60 minutes each. You could also have up to 5 optional booster sessions over the next 12 months, each lasting about 60 minutes.
Compensation
Not stated in the trial record.
Follow-up
You would be followed from enrollment to the end of treatment, which is 82 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07733310

Augmented Depression Therapy (ADepT) Case Series

Not Yet Recruiting
NAAges 18–65InterventionalTreatment
Ohio State University
~40 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Augmented Depression Therapy (ADepT)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability
Measured over From enrollment to the end of treatment at 82 weeks
+2 more outcomes measured
Depression / Major Depressive Disorder
1 sites across 1 states
Ohio1

Opens a ready-to-send draft in your own email app — review before sending.

  • AcceptabilityFrom enrollment to the end of treatment at 82 weeks

    Patient ratings of treatment acceptability

  • AttritionFrom enrollment to the end of treatment at 82 weeks.

    Patient attendance records

  • Adverse EventsFrom enrollment to the end of treatment at 82 weeks.

    Self-reported adverse events